Fady Ibraham Malik
Evp Research & Development at Cytokinetics Inc (CYTK)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 6SEC | CYTKCytokinetics Inc | Sell Plan | 3,500153,902 held (−2%) | $61.38 | $215K | +2.5% |
| Sep 22SEC | CYTKCytokinetics Inc | Sell Plan | 3,500153,902 held (−2%) | $68.29 | $239K | -7.9% |
| Sep 8SEC | CYTKCytokinetics Inc | Sell Plan | 3,500153,902 held (−2%) | $75.46 | $264K | -16.6% |
| Aug 18SEC | CYTKCytokinetics Inc | Sell Plan | 3,500153,902 held (−2%) | $75.82 | $265K | -17.0% |
| Jul 23SEC | CYTKCytokinetics Inc | Sell Plan | 3,500153,902 held (−2%) | $80.59 | $282K | -21.9% |
| Jul 7SEC | CYTKCytokinetics Inc | Sell Plan | 3,500153,902 held (−2%) | $86.62 | $303K | -27.4% |
| Jun 23SEC | CYTKCytokinetics Inc | Sell Plan | 3,500153,902 held (−2%) | $79.51 | $278K | -20.9% |
| Jun 9SEC | CYTKCytokinetics Inc | Sell Plan | 3,500153,902 held (−2%) | $67.98 | $238K | -7.5% |
| May 20SEC | CYTKCytokinetics Inc | Sell Plan | 3,500153,902 held (−2%) | $75.69 | $265K | -16.9% |
| May 5SEC | CYTKCytokinetics Inc | Sell Plan | 3,500153,902 held (−2%) | $77.37 | $271K | -18.7% |
| Apr 21SEC | CYTKCytokinetics Inc | Sell Plan | 3,500153,902 held (−2%) | $65.69 | $230K | -4.2% |
| Apr 8SEC | CYTKCytokinetics Inc | Sell Plan | 3,500153,902 held (−2%) | $65.21 | $228K | -3.5% |
| Apr 8SEC | CYTKCytokinetics Inc | Sell Plan | 1,000153,902 held (−1%) | $64.75 | $65K | -2.8% |
| Mar 18SEC | CYTKCytokinetics Inc | Sell | 7,636158,299 held (−5%) | $62.15 | $475K | +1.2% |
| Mar 18SEC | CYTKCytokinetics Inc | Sell | 4,397153,902 held (−3%) | $62.15 | $273K | +1.2% |
| Mar 10SEC | CYTKCytokinetics Inc | Sell | 2,907138,629 held (−2%) | $60.72 | $177K | +3.6% |
| Dec 16SEC | CYTKCytokinetics Inc | Sell Plan | 2,200138,552 held (−2%) | $61.24 | $135K | +2.7% |
| Dec 2SEC | CYTKCytokinetics Inc | Sell Plan | 2,200140,610 held (−2%) | $63.89 | $141K | -1.5% |
| Nov 18SEC | CYTKCytokinetics Inc | Sell Plan | 2,200140,610 held (−2%) | $66.45 | $146K | -5.3% |
| Nov 4SEC | CYTKCytokinetics Inc | Sell Plan | 2,295140,610 held (−2%) | $59.55 | $137K | +5.6% |
| Oct 21SEC | CYTKCytokinetics Inc | Sell Plan | 2,105140,610 held (−1%) | $58.22 | $123K | +8.1% |
| Oct 7SEC | CYTKCytokinetics Inc | Sell Plan | 2,000140,610 held (−1%) | $60.56 | $121K | +3.9% |
- Sell
Evp Research & Development Fady Ibraham Malik sold $215K of CYTK at $61.38 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp Research & Development Fady Ibraham Malik sold $239K of CYTK at $68.29 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp Research & Development Fady Ibraham Malik sold $264K of CYTK at $75.46 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp Research & Development Fady Ibraham Malik sold $265K of CYTK at $75.82 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp Research & Development Fady Ibraham Malik sold $282K of CYTK at $80.59 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp Research & Development Fady Ibraham Malik sold $303K of CYTK at $86.62 — pre-scheduled 10b5-1 plan sale.